Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBiphasic effects of hormone treatment on risk of cardiovascular disease
Sexuality, Reproduction & Menopause, 10/20/09
Harman MS et al. – Regularly ovulating women of reproductive age are significantly protected against CVD compared with men, but CVD increases within 10 years of menopause to levels matching or exceeding incidence rates among men,13 suggesting that ovarian estrogen may help protect women against atherosclerosis. This observation led to the corollary hypothesis that treatment of postmenopausal women with estrogens (menopausal hormone therapy [MHT]) might prevent the postmenopausal increase in CVD rates. Yet, despite more than 30 years of research attempting to define whether and how postmenopausal estrogen replacement might protect women against CVD, the issue remains uncertain and, indeed, controversial.
Related Articles
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
Women's Health, 11/02/09
Relevance Score: 96%
Changes in Postmenopausal Hormone Replacement Therapy Use Among Women with High Cardiovascular Risk
American Journal of Public Health, 10/19/09
Relevance Score: 93%
Hormone replacement therapy benefits postmenopausal women
Internet Source, 10/09/09
Relevance Score: 93%
Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women
Atherosclerosis, 11/13/09
Relevance Score: 88%
Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
EurekAlert, 10/29/09
Relevance Score: 88%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US
Current Medical Research and Opinion, 11/20/09
Metformin associated with lower cancer mortality in type 2 diabetes (ZODIAC-16)
Diabetes Care, 11/20/09
Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin
Current Medical Research and Opinion, 11/20/09
Sponsor
Article Search
Sponsor